Molecular Markers of Radiation-related Normal Tissue Toxicity

Overview

Journal Cancer Metastasis Rev

Specialty Oncology

Date 2008 May 29

PMID 18506399

Citations 27

Authors

Paul Okunieff

Yuhchyau Chen

David J Maguire

Amy K Huser

Affiliations

Soon will be listed here.

Abstract

Over the past five decades, those interested in markers of radiation effect have focused primarily on tumor response. More recently, however, the view has broadened to include irradiated normal tissues-markers that predict unusual risk of side-effects, prognosticate during the prodromal and therapeutic phases, diagnose a particular toxicity as radiation-related, and, in the case of bioterror, allow for tissue-specific biodosimetry. Currently, there are few clinically useful radiation-related biomarkers. Notably, levels of some hormones such as thyroid-stimulating hormone (TSH) have been used successfully as markers of dysfunction, indicative of the need for replacement therapy, and for prevention of cancers. The most promising macromolecular markers are cytokines: TGFbeta, IL-1, IL-6, and TNFalpha being lead molecules in this class as both markers and targets for therapy. Genomics and proteomics are still in nascent stages and are actively being studied and developed.

Citing Articles

Protective Effects of Alpha Lipoic Acid Against Ionizing Radiation- Induced Hepatotoxicity in Rats.

Gezer A, Laloglu A, Kirli Bolukbas M Eurasian J Med. 2023; 55(2):104-108.

PMID: 37403907 PMC: 10440976. DOI: 10.5152/eurasianjmed.2023.0148.

Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention.

Wiedemann J, Coppes R, van Luijk P Front Oncol. 2022; 12:931023.

PMID: 35936724 PMC: 9354542. DOI: 10.3389/fonc.2022.931023.

Longitudinal metabolic alterations in plasma of rats exposed to low doses of high linear energy transfer radiation.

Dissmore T, DeMarco A, Jayatilake M, Girgis M, Bansal S, Li Y J Environ Sci Health C Toxicol Carcinog. 2021; 39(2):219-233.

PMID: 33902389 PMC: 9896584. DOI: 10.1080/26896583.2020.1865027.

Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients.

Stanojkovic T, Matic I, Petrovic N, Stankovic V, Kopcalic K, Besu I Sci Rep. 2020; 10(1):19002.

PMID: 33149212 PMC: 7643057. DOI: 10.1038/s41598-020-75812-0.

Identification of Plasma Lipidome Changes Associated with Low Dose Space-Type Radiation Exposure in a Murine Model.

Upadhyay M, Rajagopal M, Gill K, Li Y, Bansal S, Sridharan V Metabolites. 2020; 10(6).

PMID: 32560360 PMC: 7345467. DOI: 10.3390/metabo10060252.

References

Greenberger J, Epperly M, Gretton J, Jefferson M, Nie S, Bernarding M . Radioprotective gene therapy. Curr Gene Ther. 2003; 3(3):183-95. DOI: 10.2174/1566523034578384. View

Bentzen S, Skoczylas J, Overgaard M, Overgaard J . Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst. 1996; 88(13):918-22. DOI: 10.1093/jnci/88.13.918. View

Dicker A . COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting. Am J Clin Oncol. 2003; 26(4):S46-7. DOI: 10.1097/01.COC.0000074180.16144.B3. View

Anscher M, Crocker I, Jirtle R . Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res. 1990; 122(1):77-85. View

Hancock S, McDougall I, Constine L . Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995; 31(5):1165-70. DOI: 10.1016/0360-3016(95)00019-U. View

Anscher M, Peters W, Reisenbichler H, Petros W, Jirtle R . Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med. 1993; 328(22):1592-8. DOI: 10.1056/NEJM199306033282203. View

Dubray B, Girinski T, Thames H, Becciolini A, Porciani S, Hennequin C . Post-irradiation hyperamylasemia as a biological dosimeter. Radiother Oncol. 1992; 24(1):21-6. DOI: 10.1016/0167-8140(92)90349-y. View

Mayo M, Gajewski B, Morris J . Some statistical issues in microarray gene expression data. Radiat Res. 2006; 165(6):745-8. DOI: 10.1667/RR3576.1. View

Rubin P, Finkelstein J, Siemann D, Shapiro D, Van Houtte P, Penney D . Predictive biochemical assays for late radiation effects. Int J Radiat Oncol Biol Phys. 1986; 12(4):469-76. DOI: 10.1016/0360-3016(86)90054-4. View

10.

Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

11.

Thierens H, De Ruyck K, Vral A, de Gelder V, Whitehouse C, Tawn E . Cytogenetic biodosimetry of an accidental exposure of a radiological worker using multiple assays. Radiat Prot Dosimetry. 2005; 113(4):408-14. DOI: 10.1093/rpd/nch483. View

12.

Farrell C, Rex K, Chen J, Bready J, DiPalma C, KAUFMAN S . The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif. 2002; 35 Suppl 1:78-85. PMC: 6495716. DOI: 10.1046/j.1365-2184.35.s1.8.x. View

13.

Miller S, Ferrarotto C, Vlahovich S, Wilkins R, Boreham D, Dolling J . Canadian Cytogenetic Emergency network (CEN) for biological dosimetry following radiological/nuclear accidents. Int J Radiat Biol. 2007; 83(7):471-7. DOI: 10.1080/09553000701370860. View

14.

Okunieff P, Augustine E, Hicks J, Cornelison T, Altemus R, Naydich B . Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol. 2004; 22(11):2207-13. DOI: 10.1200/JCO.2004.09.101. View

15.

Liang L, Hu D, Liu W, Williams J, Okunieff P, Ding I . Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. Am J Clin Oncol. 2003; 26(4):S114-21. DOI: 10.1097/01.COC.0000074149.95710.40. View

16.

Rubin P, McDonald S, Maasilta P, Finkelstein J, Shapiro D, Penney D . Serum markers for prediction of pulmonary radiation syndromes. Part I: Surfactant apoprotein. Int J Radiat Oncol Biol Phys. 1989; 17(3):553-8. DOI: 10.1016/0360-3016(89)90106-5. View

17.

Blakely W, Salter C, Prasanna P . Early-response biological dosimetry--recommended countermeasure enhancements for mass-casualty radiological incidents and terrorism. Health Phys. 2005; 89(5):494-504. DOI: 10.1097/01.hp.0000175913.36594.a4. View

18.

Shideler C, JOHNS M, Cantrell R, Shipe J, Wills M, Savory J . Erythrocyte polyamine determinations in patients with head and neck cancer. Arch Otolaryngol. 1981; 107(12):752-4. DOI: 10.1001/archotol.1981.00790480028007. View

19.

Cionini L, Becciolini A, Dalla Palma L, De GIULI G . Intestinal absorption of radioiodine labelled human serum albumin, mono-iodotyrosine and di-iodotyrosine following abdominal radiation therapy. Acta Radiol Ther Phys Biol. 1971; 10(3):341-52. DOI: 10.3109/02841867109130798. View

20.

Dertinger S, Miller R, Brewer K, Smudzin T, Torous D, Roberts D . Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat Res. 2006; 626(1-2):111-9. PMC: 1796663. DOI: 10.1016/j.mrgentox.2006.09.003. View